StockClub

RLMD

RLMDRelmada Therapeutics, Inc.$ --
Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-19M USD
YoY -6.8%
Net Income
-19M USD
YoY -8.5%
EPS
-0.22$
YoY +62.1%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-19.1M
FY2024 Q2$-39.6M
$-39.6M
Q2
FY2024 Q3$-61.3M
$-61.3M
Q3
FY2024 Q4$-80M
$-80M
Q4
FY2025 Q1$-17.6M
$-17.6M
Q1
FY2025 Q2$-27.4M
$-27.4M
Q2
FY2025 Q3$-37.5M
$-37.5M
Q3
FY2025 Q4$-57.4M
$-57.4M
Q4
FY2026 Q1$-19.1M
$-19.1M
Q1
Actual
$-1.5M (-8.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025MISS
Actual:$0
Est:$2.5M
FY2025MISS
$0

Analyst Estimates